| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |